- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2025-12
2035-12
2036-12
8000
NCT06713525
Herlev Hospital
Herlev Hospital
OBSERVATIONAL
Observational Copenhagen Pancreatic Cancer Study
The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.
The study objective is to describe the real-world population of patients with pancreatic cancer by collecting longitudinal data that facilitates a more rigorous understanding of the PC. This research project will catalog different elements of a patient's diagnostic and treatment journey and identify unmet needs of patients with PC. The study aims to: 1. To compile detailed demographic information of patients with PC. 2. To document and analyze the clinical and disease characteristics at the time of diagnosis and beyond. 3. To track various treatment modalities employed, including surgery, chemotherapy, and radiation therapy. 4. To assess short-term and long-term outcomes, including survival rates, complications, and quality of life. 5. To identify prognostic and predictive factors within the real-world cohort. 8. To investigate the impact of PC and treatment on patients' quality of life. 4 Study Design This study of patients with PC will employ both a prospective, observational design and retrospective design to capture real-world data relating to health status and/or the delivery of health care routinely collected from a variety of sources. Data will be collected longitudinally, allowing for a dynamic analysis of the disease trajectory.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2024-11-24 | N/A | 2024-11-27 |
2024-11-27 | N/A | 2024-12-03 |
2024-12-03 | N/A | 2024-11 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : Patients with PC are referred to Comprehensive Pancreatic Cancer Center at Herlev Hospital |
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Overall survival | 3 years |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
|
Study Contact Name: Inna Markovna Inna Markovna Chen, MD, Herlev & Gentofte Hospital, MD Phone Number: +45 3868-2898 Email: Inna.Chen@regionh.dk |
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
